Penberthy, J.K.; A. Wise, F.; Cherup, N.; Penberthy, J.M.; Mitchell, E.; Burns, M.; Akinlade, O.; Chung, D.; Parmar, H.; Singer, J.
Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol. Psychoactives 2026, 5, 12.
https://doi.org/10.3390/psychoactives5020012
AMA Style
Penberthy JK, A. Wise F, Cherup N, Penberthy JM, Mitchell E, Burns M, Akinlade O, Chung D, Parmar H, Singer J.
Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol. Psychoactives. 2026; 5(2):12.
https://doi.org/10.3390/psychoactives5020012
Chicago/Turabian Style
Penberthy, J. Kim, Fatma A. Wise, Nicholas Cherup, J. Morgan Penberthy, Evaline Mitchell, Madeline Burns, Oluwafunmilayo Akinlade, David Chung, Harshit Parmar, and Jonathan Singer.
2026. "Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol" Psychoactives 5, no. 2: 12.
https://doi.org/10.3390/psychoactives5020012
APA Style
Penberthy, J. K., A. Wise, F., Cherup, N., Penberthy, J. M., Mitchell, E., Burns, M., Akinlade, O., Chung, D., Parmar, H., & Singer, J.
(2026). Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol. Psychoactives, 5(2), 12.
https://doi.org/10.3390/psychoactives5020012
